Cardiac-specific ablation of YME1L in mice led to DCM and heart failure via activated OMA1 and accelerated OPA1 proteolysis, which triggered mitochondrial fragmentation and altered cardiac metabolism (195). Here, YME1L1 is linked to heart failure.